Aralez Pharma Balance Sheet - Quarterly (OTCMKTS:ARLZQ)

Add to My Stocks
$0.02 $0 (0%) ARLZQ stock closing price Sep 19, 2018 (Closing)
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q4
Cash43.88M28.89M40.73M55.77M73.72M64.94M56.53M93.03M114.02M24.81M
Marketable Securities----------
Receivables40.68M13.45M11.33M9.54M9.04M20.4M8.1M7.11M11.56M5.96M
Inventory5.67M6.64M4.92M4.99M4.13M4.54M4.73M4.86M4.42M-
Raw Materials----------
Work In Progress----------
Finished Goods----------
Notes Receivable----------
Other Current Assets3.06M3.68M3.32M4.16M4.77M2.43M2.96M2.88M3.68M1.22M
Total Current Assets
93.3M52.67M60.31M74.48M91.68M92.33M72.34M107.89M133.69M32M
Property Plant & Equipment----------
Accumulated Depreciation----------
Net Property Plant & Equipment
6.6M7.45M7.71M8.06M8.17M7.31M2.52M2.16M1.33M-
Investment & Advances----------
Other Non-Current Assets----------
Deferred Charges----------
Intangibles379.29M392.12M401.5M404.56M409.69M416.88M204.76M164.99M162.34M-
Deposits & Other Assets1.97M1.22M1.73M1.4M1.01M---3.46M-
Total Assets
481.17M453.47M471.26M488.51M510.56M517.37M280.31M275.74M300.84M32.25M
Notes Payable----------
Accounts Payable10.58M23.63M22.14M24.49M25.94M8.83M1.96M2.53M6.2M4.55M
Current Portion Long-Term Debt----------
Current Portion Capital Leases----------
Accrued Expenses89.87M28.49M26.04M28.91M26.27M32.14M23.55M17.62M16.8M11.93M
Income Taxes Payable----------
Other Current Liabilities16.36M15.73M12.15M13.41M16.55M16.3M4.59M4.32M7.78M-
Total Current Liabilities
116.82M67.86M60.34M66.82M68.77M57.27M30.11M24.48M34.65M16.48M
Mortgages----------
Deferred Taxes/Income2.54M3.79M3.52M3.38M3.3M3.27M6.06M6.49M7.39M-
Convertible Debt----------
Long-Term Debt274.57M274.54M274.52M274.49M274.46M274.44M74.52M74.49M74.47M-
Non-Current Capital Leases----------
Other Long-Term Liabilities93.81M92.05M73.76M68.77M67.79M62.9M19.07M---
Total Liabilities
487.75M438.25M412.14M413.48M414.34M397.89M129.77M106.03M116.96M17.47M
Minority Interest----------
Preferred Stock----------
Common Stock Net----------
Capital Surplus365.6M363.79M361.18M358.22M355.26M352.33M349.01M345.52M342.65M149.43M
Retained Earnings-382.63M-362.87M-317.1M-292.66M-265.14M-237.66M-206.55M-185.95M-168.47M-134.68M
Treasury Stock----------
Other Liabilities10.44M14.29M15.04M9.46M6.09M4.81M8.08M10.14M9.7M-
Shareholders Equity-6.57M15.21M59.12M75.02M96.22M119.48M150.54M169.71M183.87M14.78M
Total Liabilities & Shareholders Equity481.17M453.47M471.26M488.51M510.56M517.37M280.31M275.74M300.84M32.25M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Aralez Pharma Balance Sheet - Key Ratios

Current ratio
0.8
Debt to equity ratio
0
Asset turnover ratio
0.33
Receivables turnover
7.02
Price to book ratio
0.03

Quarterly Balance Sheets For Aralez Pharmaceuticals Inc Peers

Anika Therapeutics balance sheet, Auris Medical balance sheet, Skinvisible balance sheet